Ste20 is required for cell viability in S. cerevisiae when Cla4 is absent, suggesting that these two PAK homologs share an essential function [6] ; this function requires the Cdc42-binding site of Ste20 [7, 8] . To establish whether Ste20 acts as an effector of Cdc42 to promote cell growth and actin polarization, we first used a suppression strategy similar to those used frequently to order the function of gene products in signaling (reviewed in [9] ). Specifically, we determined whether overexpression of a constitutively active form of Ste20 that was coupled to glutathione-Stransferase (GST-Ste20) suppresses the temperature-sensitive growth defects and actin-polarization defects of cdc42-1 mutants. As a control, GST-Ste20 containing a mutation (K649M, in the single-letter amino-acid code) that abolishes catalytic activity was overexpressed. Overexpression of GST-Ste20 enabled cdc42-1 cells to grow at the nonpermissive temperature (37°C; Figure 1a ), whereas overexpression of inactive GST-Ste20 did not. Furthermore, GST-Ste20 overexpression restored normal cell morphology and actin cytoskeleton organization to cdc42-1 mutants at 37°C (Figure 1b) . In contrast, under identical conditions the same strain overexpressing the inactive GST-Ste20-K649M mutant exhibited cdc42-1 defects (data not shown). We also found that overexpression of GST-Ste20 in a cdc42-1 mutant that lacks Ste11 -a MAP kinase kinase kinase MEKK homolog that is activated by Ste20 -restored cell growth and actin organization at 37°C (Figure 1a and data not shown). This indicates that Ste20 can act downstream of Cdc42 to control actin polarization independent of the MAP kinase cascade activated by Ste20 during mating.
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Figure 1
Suppression of cdc42-1 growth defects and actin cytoskeletal defects by overexpression of STE20. (a) A cdc42-1 mutant (strain 186; upper half of each plate) and a cdc42-1 ste11∆ double mutant (KBY207; lower half of each plate) carried plasmids to overexpress wild-type GST-Ste20 (from pRD56; WT), a kinase-inactive ste20 allele (from pRD56-K649M; K649M) or GST alone (from pBJ383; vector). Cells were streaked on inducing selective media and incubated for 3 days at permissive (25°C) and nonpermissive (37°C) temperatures. (b) Effect of STE20 overexpression on actin organization of a cdc42-1 mutant at the nonpermissive temperature (37°C). Wild-type STE20 was overexpressed (from pRD56) in a cdc42-1 mutant (DDY932); controls were non-plasmid-containing cdc42-1 mutant and wild-type cells (DDY903). Anti-actin antibody immunofluorescence is shown. Figure 2a ).
To determine whether loss of Cla4 and Ste20 affects cell morphology and actin distribution in vegetatively growing cells, we constructed a cla4∆ ste20∆ double mutant carrying the wild-type STE20 gene expressed from a regulatable promoter. When expression of STE20 was repressed at 37°C, 60% of the cells were large and unbudded with multiple nuclei, resembling cdc42-1 mutants. These effects appear to be direct as unbudded cells began to accumulate at 4 h and cell death was first observed at 14 h. Other cells in the population were budded but showed defects in cytokinesis (28%), or had no buds (12%) and appeared elongated rather than ellipsoidal. In all three classes of arrested cells, the actin cytoskeletons were depolarized ( Figure 2b ).
To further examine whether PAKs regulate polarization of the actin cytoskeleton, we took advantage of the fact that actin polarization and bud emergence in yeast occur in response to activation of Cdc28, a cyclin-dependent kinase associated with G1 cyclins [10] . Certain temperature-sensitive cdc28 mutations cause cells to arrest at 37°C as elongated cells with a polarized actin cytoskeleton [11] . We found that deletion of STE20, but not CLA4, in a cdc28-4 mutant resulted in the loss of actin polarization and the appearance of round, unbudded cells at the nonpermissive temperature ( Figure 2c ), as seen in cdc42-1 mutants. These effects were not due to lack of MAP kinase activation because actin polarization and elongated cell morphology were observed when STE7, which encodes the MAP kinase kinase homolog MEK in the pheromone-response pathway, was deleted in the cdc28-4 mutant ( Figure 2c ). Thus, the results of several approaches implicate the yeast PAK homolog Ste20 in regulation of the cortical actin cytoskeleton in vivo, and suggest that Ste20 and Cla4 have both common and distinct functions.
To determine whether Ste20 can regulate actin organization directly, we used an in vitro actin-assembly assay employing permeabilized yeast cells. This assay has been used previously to show that actin assembly depends upon active Cdc42 [12] . In permeabilized cla4∆ and ste20∆ single mutants, severe defects in actin-assembly activity were observed (Table 1) , similar to those in cdc42-1 mutants. These defects were corrected by wild-type GST-Ste20, but not by the K649M mutant. The in vitro defects observed for the single cla4∆ and ste20∆ mutants might be more severe than the in vivo defects because other Cdc42 effectors (namely, Gic1 and Gic2 [13, 14] or Bni1 and Bnr1 [15, 16] ) might compensate for a deficit in kinase function in living cells.
We next tested whether GST-Ste20 could correct the actin-assembly defect of permeabilized cdc42-1 mutants, and found that incubation of cdc42-1 cells with GST-Ste20 allowed 64% of small-budded permeabilized cells to assemble rhodamine-actin in the bud ( Figure 3 ; Table 1 ). In contrast, only 27% of cdc42-1 cells treated with buffer alone assembled rhodamine-actin. GTPbound Cdc42 restores actin assembly of permeabilized cdc42-1 mutants to a similar extent [12] . Relative to controls, GST-Ste20-treated cells assembled significantly more rhodamine-actin because the rhodamine fluorescence was more intense (data not shown). GST-Ste20 also stimulated actin assembly in permeabilized cdc42-1 ste11∆ double mutants, although not as efficiently as in cdc42-1 cells (Table 1 ). This provided a further indication that Ste20 can regulate actin assembly independently of the MAP kinase pathway involved in pheromone response, pseudohyphal differentiation and invasive growth.
The effects of GST-Ste20 on actin assembly in vitro were specific. First, actin-assembly defects of permeabilized mutants lacking Sla1 [12] , a structural component of the actin cytoskeleton, were not restored by Ste20 (Table 1) even though addition of a source of wild-type Sla1 can restore assembly (J.J.E. and K. Ayscough, unpublished observations). This suggests that GST-Ste20 corrects actin-assembly defects caused by deficits in pathways controlled by Cdc42. Second, other protein kinases (protein kinase A (PKA), protein kinase C (PKC), or GST-Ste11) failed to restore actin-assembly activity in permeabilized cdc42-1 cells, even when markedly higher levels of kinase activity were employed (data not shown). The observation that GST-Ste11 was inactive in this assay supports the conclusion that actin assembly induced by GST-Ste20 does not involve MAP kinase activation.
Our analysis highlights the role of the PAK homolog Ste20 as a downstream effector of Cdc42 that regulates the actin cytoskeleton by a mechanism independent of MAP kinase activation. This conclusion is consistent with the observations that Ste20 localizes to regions of the yeast cell cortex where actin is polarized [7, 8] and that Ste20 can be isolated from yeast extracts in a protein complex containing actin [17] . Similar pathways are likely to regulate actin organization in metazoan organisms. In Drosophila and mammalian fibroblasts, PAKs localize to focal adhesions and membrane ruffles [18] [19] [20] , and expression of activated PAK mutants induces actin reorganization [19, 21] . Furthermore, PAK-like kinases activate myosin I [22] [23] [24] , which may facilitate cortical actin assembly in vivo, and inhibition of PAKs blocks some of the cytoskeletal rearrangements triggered by activated Rac1 or Cdc42 [25] .
PAKs are likely to be one of several types of effectors that mediate actin cytoskeletal reorganization in response to activated Rac1 or Cdc42 because overexpression of Rac1 or Cdc42 mutants defective in binding PAKs but not other effectors triggers actin cytoskeletal rearrangements in fibroblasts [3] [4] [5] . Furthermore, overexpression of Wiskott-Aldrich syndrome protein (WASP) in mammalian cells promotes actin reorganization [26] , and loss of the yeast Cdc42-binding proteins Gic1 and Gic2 [13, 14] and Bni1 or Bnr1 [15, 16] Yeast cells were synchronized at the small-budded cell-cycle stage and permeabilized as described in the Materials and methods [12] . Permeabilized cells were incubated in buffer or with the indicated purified GST-Ste20 fusion proteins. Numbers reflect the average percentage of cells that assembled rhodamine-actin in the bud and the number of times the assay was performed to obtain this average.
Figure 3
Rescue of actin-assembly defects of permeabilized cdc42-1 cells by GST-Ste20 in vitro. Rhodamine-fluorescence micrographs of cdc42-1 mutants (DDY932) grown at 34°C, permeabilized, incubated with buffer alone or with purified GST-Ste20, and subsequently with rhodamine-labeled actin under assembly-inducing conditions. Experiments were performed three or more times in two different strain backgrounds, which gave similar results.
of PAKs in yeast may reveal how this class of effector regulates the actin cytoskeleton in a variety of organisms.
Materials and methods

Phenotypic analyses
The effects of depleting Ste20 in a ste20∆ cla4∆ double mutant (DDY1414) containing an integrated GAL-STE20 construct were determined as follows. Cells were grown in media containing 2% galactose to mid-log phase (OD 600 = 0.15), harvested, washed, suspended in fresh media containing glucose or galactose and incubated at various temperatures. Culture aliquots removed at 2 h intervals were fixed and stained with rhodamine-phalloidin and DAPI. The effects of deleting STE20 in a cdc28-4 mutant were determined by shifting midlog cultures (a cdc28-4 mutant, a cdc28-4 ste20∆ double mutant or a cdc28-4 ste7∆ double mutant) from 25°C to 37°C for 6 h. Cells were washed in PBS-sorbitol, fixed and stained with rhodamine-phalloidin.
Actin-assembly assays
Wild-type (DDY903) and cdc42-1 mutant (DDY932) cells were grown at 34°C to early log phase (OD 600 = 0.15-0.25), and treated with α-factor (2 µg/ml final concentration) to arrest cells in G1. Alternatively, for experiments involving cla4, ste20, or sla1 single mutants or cdc42-1 ste11 double mutants, G1 cells were enriched by differential centrifugation as described [12] . G1 cells were washed twice with fresh media and incubated at 34°C until most cells had exited G1 and formed small buds. Cell permeabilization and actin assembly assays using rhodamine-actin were performed as described [12] . Prior to rhodamine-actin addition, permeabilized cells were incubated 10-30 min at 25°C with 1 mM ATP with or without GST-Ste20, GST-Ste11, PKC-M or PKA catalytic subunit in a final volume of 20 µl.
Supplementary material
A list of strains and plasmids used in this study as well as sources of kinases and further details of microscopy and phenotype analysis are published with this paper on the internet. 
Actin cytoskeleton organization regulated by the PAK family of protein kinases
Phenotypes
Wild-type yeast cells contained a network of actin cables aligned along the mother-bud axis and patches of actin concentrated at actively growing areas of the cell cortex. cdc42-1 mutants grown at the nonpermissive temperature (37°C) were large, round, unbudded and contained depolarized actin cytoskeletons. Overexpression of GST-Ste20, but not inactive GST-Ste20-K649M, suppressed the morphological and cytoskeletal defects caused by the cdc42-1 mutation at 37°C. Repression of Ste20 expression in cla4∆ ste20∆ double mutants at temperatures lower than 37°C had different effects on cell morphology than those observed at 37°C. Most notably, at 25°C and 33°C, respectively, 60% and 39% of the cells had a single long, thin bud with a single nucleus located in the mother cell.
Materials and methods
Plasmids
The plasmids used to overexpress GST-Ste20 (pRD56) or GST alone (pBJ383) were provided by A. Neiman and J. Cooper, respectively. A mutation (K649M) disrupting the catalytic activity of GST-Ste20 was constructed using the polymerase chain reaction (PCR), sequenced and introduced into pRD56 by swapping a BalI-NarI fragment, producing pRD56-K649M. 
Strains used in this study
Microscopy
For permeabilized cell assays, cdc42-1 and cdc42-1 ste11∆ double mutants were grown at 28°C prior to permeabilization. Cells were viewed with a Zeiss Axioskop epifluorescence microscope equipped with a Zeiss 100× Plan-Neofluor oil immersion objective. Images were acquired with a 200-E CCD camera (Sony Electronics Inc., San Jose, CA) using Northern Exposure software (Phase 3 Imaging Systems, Milford, MA).
Protein kinase purification and assays
GST-Ste20 and GST-Ste11 were purified from yeast, as described [S1]. Purified GST-Ste20 did not contain detectable levels of Cdc42, Cdc24, Bem1, Akr1, or Boi1, as indicated by immunoblotting (specific antibodies provided by J. Pringle, D. Johnson, and A. Bender).
GST-Ste11 autophosphorylation was used to detect its activity [S1]. GST-Ste20 activity was quantified using myelin basic protein (MBP); it was constitutively active toward MBP and kinase-inactive GST-Ste11 (data not shown).
Materials
Activated PKC-M (trypsin-cleaved rat brain PKC; Calbiochem) was 50-fold more active than GST-Ste20 using MBP as a substrate. Recombinant catalytic subunit of PKA (murine) was obtained from New England Biolabs. A unit of kinase activity is defined as 1 nmol phosphate transferred to substrate (MBP for GST-Ste20; histone H1 for PKC-M; kemptide for PKA) per minute at 30°C.
